FHL3 and hepatocellular carcinoma: Subsequent studies revealed that FHL3 is upregulated in HCC tissues and associated with poor prognosis in HCC patients, and that FHL3 can promote the proliferation and invasion of HCC cells both in vitro and in vivo.